Founders Fund, backed by Thiel, raises $280 million for Musk’s Neuralink
Months after receiving permission for its first in-human clinical study, Peter Thiel’s Founders Fund led a $280 million investment round for Elon Musk’s brain chip business Neuralink.
The valuation used to raise the financing was kept a secret by the corporation. According to Reuters, the company’s valuation after secret stock trades was roughly $5 billion in June.
The business expressed its excitement for the upcoming chapter in a post on the X social media site, previously known as Twitter and owned by Elon Musk.
Employees at Neuralink told Reuters last year that Musk was pressuring them to get FDA approval, which caused the company to hurry and botch surgery on monkeys, pigs, and sheep, killing more animals than necessary.
According to the sources, data from the company’s animal research was used to bolster its application for human trials.
After Reuters revealed potential financial conflicts on the panel governing Neuralink’s animal research, U.S. senators requested regulators to look into whether this contributed to the hurried and flawed tests.
